CHRISTINA MCMILLAN: Open Payments
NPI 1669815957 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 7 companies in 2025. Trend: 2023 $354 · 2024 $218 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $72 |
| Biogen, Inc. | 2 | $52 |
| Organon LLC | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Exeltis, USA Inc. | 1 | $24 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: GEMTESA, ZURZUVAE, NEXPLANON, Lynkuet, SLYND, MYFEMBREE, Veozah.
Industry payments across VA — which companies pay providers there.
